AACR Virtual Annual Meeting, 2021

Session Type:      E-Poster Session
Session Category:        Immunology
Session Title:        Immunomodulatory Agents and Interventions
Presenter:      Dr. Emma Langley
Permanent Abstract Number:        1745

February 27, 2020

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform,  February 27, 2020, Ingelheim, Germany and San Diego, California

Boehringer Ingelheim will work with Trutino Biosciences to access the company’s OnDemand-Cytokine™ (ODC) platform to develop new cancer immunology compounds. The partners aim to develop safer, more tolerable and more effective cytokine therapies for single agent and novel combinations with Boehringer Ingelheim’s innovative cancer vaccine, oncolytic virus, T cell engager and myeloid-targeting therapies

Boehringer Ingelheim Press Release – 2/27/2020

Ingelheim, Germany and San Diego, California – 27 February 2020 –

Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and
worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine (ODC) platform.
Under the terms of strategic alliance, Boehringer Ingelheim gains access to Trutino’s ODC platform
technology for the generation and development of up to three new ODC candidates. This new
collaboration combines Boehringer Ingelheim’s long-term strategy to provide first-in-class, breakthrough
therapies for cancer patients with Trutino’s unique knowledge and expertise in increasing the safety and
efficacy of cytokine therapies

Read more

Biocom’s 10th Annual Global Life Science Partnering Conference, February 25-27 2020, La Jolla, CA

This event is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.  Industry leaders will debate current trends, companies will showcase their latest technologies.

AACR Annual Meeting, April 24-29 2020, San Diego, CA (Postponed)

Due to technical difficulties, the AACR Annual Business Meeting of Members has been postponed and will be held at a later date.

Executive and scientific leaders from Trutino Biosciences will be attending AACR Annual meeting being held in San Diego. Please check here soon for details regarding our presentation.

38th Annual J.P. Morgan Healthcare Conference, Jan. 13-16 2020, San Francisco, CA

Phillip Kim, CEO and founder of Trutino Biosciences, will be attending the 38th Annual J.P. Morgan Healthcare conference in San Francisco.

If you are interested in scheduling a meeting to learn more about the next generation of cancer immunotherapies that we are developing and the innovative platform technology we are employing, please email